Abstract
Background
Group‐based trajectory modeling has been applied to identify distinct trajectories of growth across the life course. Objectives of this study were to describe the methodological approaches for group‐based modeling of growth across the life course and to summarize outcomes across studies.
Methods
A scoping review with a systematic search of Medline, EMBASE, CINAL, and Web of Science was conducted. Studies that used a group‐based procedure to identify trajectories on any statistical software were included. Data were extracted on trajectory methodology, measures of growth, and association with outcomes.
Results
A total of 59 studies were included, and most were published from 2013 to 2020. Body mass index was the most common measure of growth (n = 43). The median number of identified trajectories was 4 (range: 2–9). PROC TRAJ in SAS was used by 33 studies, other procedures used include TRAJ in STATA, lcmm in R, and Mplus. Most studies evaluated associations between growth trajectories and chronic disease outcomes (n = 22).
Conclusions
Group‐based trajectory modeling of growth in adults is emerging in epidemiologic research, with four distinct trajectories observed somewhat consistently from all studies. Understanding life course growth trajectories may provide further insight for population health interventions.
Keywords: body weight, growth mixture modeling, latent class growth analysis, life course
1. BACKGROUND
The prevalence of obesity has nearly tripled globally over the past 40 years. 1 Specifically, in children, 18.5% are considered to have obesity, which is concerning as this may impact health‐related outcomes, including obesity, later in life. 2 It is important to understand the life course patterns or trajectories of obesity as these may differentially impact health related outcomes. 3 It is common for researchers to measure obesity at a single time‐point; however, a single time‐point may not adequately represent disease risk and etiology and does not address the potential heterogeneity of growth patterns across the life course. 4 Within populations, heterogeneous patterns of body mass index (BMI) or body size over the life course exist. Identifying homogeneous groups that have followed similar trajectories can provide important insight for both treatment and prevention and for understanding disease risk. 5 Specific groups of people that share similarities in growth patterns may be differentially at risk for development of chronic diseases later in life.
Several approaches can be used to measure growth over the life course. Characterization of growth can be done using growth curves that assess individual change over time, or through group‐based methods, which identify groups of individuals who share underlying characteristics. 6 , 7 The use of group‐based procedures to categorize patterns of growth is an emerging method in epidemiology; however, the methods associated with generating group‐based trajectories vary. Two common methods include latent class growth analysis or growth mixture modeling which are finite mixture modeling approaches that identify groups of individuals who share underlying characteristics. 8 The advantages of using group‐based procedures to understand growth over the life course are the potential identification of sensitive or critical periods of exposure. There are periods of accelerated growth in childhood and the incidence and remission of obesity changes with age. 9 Understanding the impact of accumulation of risk or change in risk of obesity across the life course may help to better understand the risk of disease various chronic diseases. 6 , 7
A previous systematic review of group‐based trajectory modeling for BMI trajectories only in childhood, starting at birth, found that most studies identified three or four distinct trajectories; however, there were several inconsistencies in terms of methodologies used to identify trajectories. 10 A limitation of the previous review is that it only included studies that had a measure of growth at birth and only those that used BMI as the anthropometric measure. There have been no reviews that included measures of growth for adults over the age of 18. Thus, the primary objective of this study is to review the methodological approaches and results of group‐based modeling studies of growth across the life course. A secondary objective is to describe the outcomes associated with growth trajectories.
2. METHODS
2.1. Study design
A systematic scoping review was conducted. This protocol review was registered with PROSPERO (CRD‐42019129356). The preferred reporting items for systematic reviews and meta‐analyses extension for scoping reviews guidelines were followed for the reporting of this study.
2.2. Eligibility criteria
Studies were included if a group‐based approach to construct trajectories of anthropometric measures were used. Inclusion criteria were that all studies had at least three repeated anthropometric measures taken over a period of at least 1 year, and at least 1 measure had to be recorded while the participant was >18 years of age. According to Medical Subject Headings 11 and World Health Organization, 12 growth is defined as a gradual increase or development in cells that results in changes in body weight or height. Therefore, any anthropometric measures to assess growth (e.g., BMI, height, weight, waist circumference, body size, waist‐to‐hip, and skinfold thickness) were included. Any exposures or outcomes evaluated in relation to the growth trajectories were eligible for inclusion into the review. Studies were excluded if they focused on a specific clinical population, for example, only people with diabetes, spinal cord injuries, or who were pregnant. Studies that looked at growth velocity or modeled weight gain or weight loss after a medical procedure were also excluded. Any year of publication or study design were included; however, only studies published in English and primary studies were included (abstracts and review papers were excluded).
2.3. Search strategy
A systematic search was conducted in August 2020 using four databases: Medline, EMBASE, CINAL, and Web of Science. The search strategy was developed with assistance from health research librarians at McMaster University. Search strategies were developed and modified for the specific criteria of each database. Search terms fell into two categories: latent class growth modeling and anthropometric measures (BMI, weight, etc.). The sample search for EMBASE can be found in Table 1. Search strategies for the remaining databases can be found in the Tables A1–A3. The reference lists of included studies were reviewed to determine any further studies that were eligible for inclusion into the study.
TABLE 1.
EMBASE search strategy
| 1 | “Latent growth model*”.mp OR “latent class growth mixture model*”.mp OR “growth mixture model*”.mp OR “latent growth model*”.mp OR “latent class growth analysis”.mp OR “latent class growth analyses”.mp OR “group based trajectory model*”.mp OR “group based trajectory analysis”.mp OR “group based trajectory analyses”.mp OR “group based model*”.mp OR “latent growth mixture model*”.mp OR “group based trajectory*”.mp |
| 2 | Growth/OR obesity/OR anthropometry/OR exp body mass/OR exp anthropometric parameters/OR exp body weight/ |
| 3 | 1 AND 2 |
| 4 | Limit 3 to (human and English language) |
| 547 |
2.4. Study selection
Once searches were conducted in all databases, studies were imported into Covidence. Covidence is a web‐based software used to maintain records throughout the various stages of conducting a systematic review. 13 All duplicates were identified and then removed prior to beginning screening. Studies were screened at title and abstract level, and then at full text by three independent reviewers (Vanessa De Rubeis, Alessandra Andreacchi, Isobel Sharpe). Conflicts at both title and abstract level and full‐text level were resolved by the reviewers and a final decision was then made regarding inclusion of the study.
2.5. Data extraction
All eligible studies had data extracted by two independent abstractors (Vanessa De Rubeis, Alessandra Andreacchi, Isobel Sharpe). Any conflicts that arose during data extraction were resolved by a third reviewer (Vanessa De Rubeis, Alessandra Andreacchi, Isobel Sharpe). A data extraction template on Microsoft Excel was used to organize the information extracted from each study. Data on the general characteristics of the study, including the author, year of publication, name of study, sample size, and population were extracted. Data were also extracted on the methodology used to generate trajectories, including statistical modeling methods, statistical software used, and model fit criteria. Trajectory details were also extracted, which included the number of trajectories, the shape of trajectories (e.g., cubic, quadratic), names of trajectories, and proportion of people in each trajectory. The measures of growth used to identify the trajectories, the number of measures, and the period of life course which the trajectories encompass were also extracted. Finally, details regarding if the growth trajectories were considered as an exposure or outcome were extracted, and in studies where growth trajectories were the exposure, associations with outcomes were extracted.
3. RESULTS
A total of 7170 studies were identified from the search and three additional studies were identified from the reference lists of the included studies. Six hundred and seventy‐three duplicates were identified and removed. There were 6497 studies that were screened at title and abstract level and 158 of these studies were screened for eligibility at full‐text level. A total of 59 papers met the inclusion criteria and were included in this review. A detailed description of the screening process can be found in Figure 1.
FIGURE 1.

Preferred reporting items for systematic reviews and meta‐analyses flow chart
3.1. Description of studies
A summary of study characteristics can be found in Table 2. Of the 59 papers included in this review, 40 unique study populations were represented. For instance, there were six studies (10%) from the Nurses' Health Study and Health Professionals Follow‐Up Study 14 , 15 , 16 , 17 , 18 and four studies (7%) from the US National Longitudinal Survey of Youth (NLSY). 14 , 15 , 16 , 17 , 18 Most of the papers included North American populations, with 28 (47%) studies from the United States, five (8%) studies from Canada, and one study from Mexico. The remaining studies were conducted in Asia (n = 8, 14%), Australia and New Zealand (n = 3, 5%), and 14 studies (24%) were published from European countries. Most studies were published from 2013 to 2019 (n = 55). Few studies were restricted to males (n = 4) 14 , 15 , 16 , 17 , 18 or females (n = 8) 14 , 28 , 29 , 30 , 31 , 32 , 33 , 34 only. Of the 47 studies that included both males and females, 18 studies reported trajectories only stratified by sex. The most common study design used was a cohort study (n = 55), three studies were case‐control designs 27 , 30 , 35 with measures of recalled body size from different age periods and one study was a randomized control trial. 27 , 30 , 35 Table A4 in the Appendix outlines more detailed characteristics of the included studies.
TABLE 2.
Characteristics of included studies (n = 59)
| Characteristics | N (%) |
|---|---|
| Place of publication | |
| Australia/New Zealand | 3 (5) |
| Asia | 8 (14) |
| Europe | 14 (24) |
| North America | 34 (58) |
| Year of publication | |
| 2017–2020 | 33 (56) |
| 2013–2016 | 22 (37) |
| 2009–2012 | 4 (7) |
| Study design | |
| Cohort study | 55 (93) |
| Case‐control study | 3 (5) |
| Randomized trial | 1 (2) |
| Sex | |
| Male only | 4 (7) |
| Female only | 9 (15) |
| Both | 46 (78) |
| Sample size | |
| ≥10,000 | 16 (27) |
| 5000–<10,000 | 18 (31) |
| ≤5000 | 25 (42) |
| Software used to generate trajectories | |
| Mplus | 11 (19) |
| R | 4 (7) |
| SAS | 33 (56) |
| Stata | 11 (19) |
| Number of trajectories a | |
| 2 | 9 (15) |
| 3 | 13 (22) |
| 4 | 33 (56) |
| 5 | 19 (32) |
| >6 | 8 (14) |
| Anthropometric measure used a | |
| Body shape b | 11 (19) |
| Body weight | 2 (3) |
| Self‐reported BMI | 26 (44) |
| Measured BMI | 16 (27) |
| Other c | 6 (10) |
| Period of life | |
| Birth to adulthood | 1 (2) |
| Childhood to adulthood | 21 (36) |
| Adulthood | 37 (63) |
| Stratified trajectories | |
| Sex stratified | 19 (32) |
| N/A | 40 (68) |
| Mean number of trajectories (SD) | 4.2 (1.4) |
| Mean number of growth measures used d (SD) | 6.2 (2.7) |
Abbreviation: BMI, body mass index; N/A, Not applicable; SD, Standard deviation.
Does not equal to 100% since studies included trajectories for multiple measures or stratified trajectories.
Body shape assessed used somatotypes or body silhouettes.
Body fat percentage, lean mass, total body fat mass, skinfold thickness, waist circumference.
Six studies did not provide exact number of measures used and only reported a range, therefore were not included in mean calculation.
3.2. Growth measures used and period of life
Table 3 summarizes the growth measures and methods that were used to identify trajectories. BMI was the most commonly used growth measure (n = 43). Two studies estimated distinct trajectories for more than one measure of growth. 26 , 36 Of the 43 studies that used BMI, 27 (63%) relied on self‐report, and the remaining 16 (37%) used directly measured height and weight by trained research assistants. Eleven studies used body shape as the growth measure. To measure body shape, studies used pictures or somatotypes, ranging from lean to overweight, which assist in recall of past or current body size. Two studies 26 , 36 used measured weight (unadjusted for height) to estimate trajectories. Body fat percentage, 26 , 36 total lean mass, 26 , 36 total body fat mass, 26 , 36 skinfold thickness, 26 , 36 and waist circumference 26 , 36 were also used to estimate trajectories in one study each. One study 40 modeled percent change of BMI from the baseline measure at 20 years of age. No studies used height only as a measure growth.
TABLE 3.
Detailed description of trajectory methodology of included studies (N = 59)
| Author, year | Trajectory method | Model fit criteria | Shape | Software | Number of trajectories | Trajectory name (%) | Resolving trajectory | Anthropometric measure | Period of life | Number of measurements | Duration of measurements |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adane, 2018 28 | N/A |
BIC A priori knowledge about BMI trajectories in adults Size of trajectory group (5% cutoff) Average group membership probability Meaningfulness of groups for analyses |
N/A | SAS—proc traj | 3 |
|
No | Self‐reported BMI | Adulthood—preconception (25–32 years) | 3 | 6–7 years |
| Ahanchi, 2019 51 | LCGMM |
|
Quadratic | Mplus |
|
|
No | Measured BMI | Adolescence (12 years)–young adulthood (20 years) | 5 | ∼16 years |
| Amadou, 2014 30 | Discrete mixture model |
|
Quadratic and cubic function | SAS—proc traj | 5 |
|
No | Body silhouettes | Childhood (6–11 years of age)–midadulthood (25–35 years of age) | 6 |
|
| Botoseneanu, 2013 52 | SPMM |
|
Quadratic | SAS—proc traj | 5 |
|
No | Self‐reported BMI | Adulthood (∼55 years)–older adulthood | 4–11 | Mean 5.5 years (2.2–11.3 years) |
| Buscot, 2018 49 | LCGMM |
|
Quadratic | R—lcmm | 6 |
|
Yes (class 2 crosses over) | Measured BMI | Childhood–adulthood (6–49 years of age) | 16 | 31 years |
| Clarke, 2010 69 | Generalized growth mixture modeling |
|
Linear | Mplus—FIML | 2 |
|
No | Self‐reported BMI | Early adulthood (19–35 years) | 7 | 55 years |
| Clarke, 2013 58 | Generalized growth mixture modeling |
|
Linear and quadratic | Mplus—FIML | 2 |
|
No | Self‐reported BMI | Early adulthood (19/20 years–29/30 years) | 3 or more measures including baseline and year 10 | 10 years |
| Dai, 2019 72 | GBTM |
|
Linear | STATA—traj plugin | 4 |
|
No | Measured BMI | Midadulthood (32–57 years) | 6 | 5 years |
| De rubeis, 2019 35 | LCGMM |
|
Quadratic | SAS—proc traj | 5 |
|
No | Self‐reported recall BMI | Early adulthood (20s)–older adulthood (50s–60s) | 4 | ∼40 years (teenage years to 80s) |
| Elrashidi, 2016 60 | Nonparametric hill climbing algorithm | Calinski and Harabatz criterion | N/A | SAS—proc traj | 4 |
|
No | Measured BMI | Early adulthood—adulthood (>18 at baseline– < 51 at final measurement) | 12 | 4 years |
| Elsenburg, 2017 41 | Growth mixture modeling |
|
Linear and quadratic | Mplus—FIML | 3 |
|
No | Measured BMI | Childhood (10–12 years)–early adulthood (21–23 years) | 5 | 13 years |
| Fagherazzi, 2013 31 | Nagin's approach to group based modeling |
|
Cubic | SAS—proc traj | 6 |
|
Yes (T3 resolves after menarche) | Body shape | Childhood (8 years)–midadulthood (35–40 years) | 4 | 32 years |
| Fagherazzi, 2015 32 | Nagin's approach to group based modeling |
|
Cubic | SAS—proc traj | 6 |
|
No | Body shape | Childhood (8 years)–midadulthood (35–40 years) | 4 | 32 years |
| Fan, 2019 66 | LCGMM |
|
Cubic | R—lcmm | 4 |
|
No | Measured BMI | Young adulthood (20–40 years) | 3 or more | 7 years |
| Hang, 2018 14 | Group‐based trajectory modeling |
|
Cubic | SAS—proc traj | 5 |
|
No | Body shape | Children to older adulthood (5–60 years of age) | 9 | 16 years |
| Ho, 2019 70 | Group‐based analysis | BIC | N/A | SAS—proc traj | 4 |
|
No | Self‐reported BMI | Older adulthood (average 61 years) | 3 | 8 years |
| Huang, 2013 80 | Group based dual trajectory modeling |
|
Linear | SAS—proc traj | 3 |
|
No | Self‐reported BMI | Early adulthood (20–24 years) | 9 | 55 |
| Islam, 2019 46 | LCGM |
|
Linear and quadratic | SAS—proc traj | 4 |
|
No | Measured BMI | Childhood (6 years of age)–older adulthood (80 years of age) | 6 | 11 years (19–30) |
| Ito, 2020 34 | Group‐based trajectory modeling | N/A | N/A | SAS—proc traj | 4 |
|
Yes | Self‐reported BMI | Midadulthood (40s)—Older adulthood (>60 years) | 6 | 10 years |
| Jayne, 2019 53 | GBTM |
|
N/A | Stata—traj procedure | 4 |
|
Yes | Measured BMI | Adulthood (3‐year duration) | 5 | 3 years |
| Jeon, 2019 39 | GBTM |
|
|
SAS—proc traj | 5 |
|
No | Waist circumference | Midadulthood (>40 years) | 4 | 6.2 years |
| Jun, 2012 15 | General growth mixture modeling |
|
N/A | Mplus | 4 |
|
Yes (obese to overweight trajectory) | Self‐reported BMI | Early adulthood (25–29 years) –older adulthood (55–59 years) | 7 | 74 years |
| Kakoly, 2017 33 | GBTM | N/A | N/A | STATA | 3 |
|
No | Self‐reported BMI | Early adulthood (20–36 years) | 5 | 16 years |
| Kelly, 2017 25 | LCGMM |
|
Linear and quadratic | SAS—proc traj | 5 |
|
No | Self‐reported BMI | Early adulthood (20 years) –older adulthood (62.5 years) | 3 | 40 years (20 years to current, mean 62 years) |
| Kuchibhatla, 2013 64 | Generalized mixture modeling |
|
Linear and quadratic | Mplus—GMM | 3 |
|
No | Self‐reported BMI | Older adulthood (baseline to 10 years follow‐up; 65–75 years) | 4 | 10 years |
| Kvoerner, 2018 18 | GBTM |
|
Quadratic | SAS—proc traj | 5 |
|
No | Somatotype (for some measures, converted BMI to somatotype) | Childhood (5 years)–older adulthood (60 years) | 9 | 18 years |
| Kwon, 2015 38 | Group‐based trajectory analyses |
|
Quadratic | STATA—TRAJ | 4 |
|
Yes (only in males) | Body fat percentage | Childhood (5 years)–young adulthood (19 years) | 7 | 11 (12–23 years) |
| Laddu, 2017 26 | GBTM |
|
Quadratic | STATA—TRAJ |
|
|
Yes |
|
Older adulthood (6.9 years (does not indicate ages but ≥65 at baseline mean = 73.7 [5.9]) | 3 | 6.9 years total follow‐up (visit 2 and 3 were an average 4.6 and 6.9 years after visit 1/baseline) |
| Lavalette, 2020 27 | Group‐based trajectory modeling |
|
|
SAS—proc traj | 5 |
|
No | Self‐reported BMI | Young adulthood (20s)–older adulthood (>70 years) | 5 (2–6) | ∼50 years |
| Lisan, 2018 47 | GBTM |
|
N/A | SAS—proc traj | 5 |
|
No | Body silhouettes | Childhood (8 years) –midadulthood (45 years) | 5 | 37 years |
| Lisan, 2019 48 | GBTM |
|
N/A | SAS—proc traj | 9 |
|
No | Body silhouettes | Childhood (8 years)–midadulthood (45 years) | 5 | 37 |
| Malhotra, 2013 19 | GBTM |
|
Linear | SAS—proc traj | 5 |
|
No | Self‐reported BMI | Young adulthood (25 years)–midadulthood (33 years) | Average 8.76, maximum 11 | 18 years |
| Nonnemaker, 2009 20 | GGMM |
|
Quadratic | Mplus | 4 |
|
No | Self‐reported BMI | Childhood (12 years)–early adulthood (23 years) | 7 | 16 years |
| Ostbye, 2011 21 | LCGM |
|
Linear and quadratic | SAS—proc traj | 4 |
|
No | Self‐reported BMI | Young adulthood (18 years)–midadulthood (49 years) | 10 | 30 years |
| Oura, 2019 50 | LCGM |
|
Linear and quadratic | SAS—proc traj | 3 |
|
No | Measured BMI (z‐score) | Birth (0 years)–midadulthood (46 years) | 5 | 46 |
| Petrick, 2017 59 | Latent class group‐based mixture model analysis |
|
Quadratic | SAS—proc traj | 4 |
|
No | Self‐reported BMI | Early adulthood (20 years)–older adulthood (mean | 3 | 59 years |
| Reinders, 2015 63 | Group‐based trajectory modeling |
|
Linear | STATA proc traj | 4 |
|
No | Measured BMI | Older adulthood (70–79 at baseline) | 12 | 35 years |
| Salmela, 2020 71 | GBTM |
|
STATA traj plug in | 4 |
|
No | Self‐reported BMI | Midadulthood (40s)–adulthood (60s) | 4 | 17 years | |
| Sayon‐Orea, 2019A 42 | GBTM |
|
Cubic and quadratic | STATA traj plug in | 4 |
|
No | Body shape/somatotype | Childhood (5 years)–midadulthood (40 years) | 5 | 35 years |
| Sayon‐Orea, 2019B 43 | GBTM |
|
Quadratic and cubic | Stata traj plug in | 4 |
|
No | Body shape/somatotype | Childhood (5 years)–midadulthood (40 years) | Max of 5 (at age 5, 20, 30, 40, and present) but at least 3 somatotype data | 35 years |
| Song, 2016A 5 | Group‐based modeling | BIC | Cubic | SAS—proc traj | 5 |
|
No | Somatotypes | Childhood (ages 5, 10)–adulthood (ages 20, 30, 40, 50, 60) | 7 | 14 |
| Song, 2016B 16 | Group‐based modeling | BIC | Cubic | SAS—proc traj | 5 |
|
No | Somatotypes | Childhood (ages 5, 10)–adulthood (ages 20, 30, 40, 50) | 6 | 45 years |
| Song, 2018 17 | Group‐based modeling (did not specify) | BIC | Cubic | SAS—proc traj | 4 |
|
No | Somatotypes | Childhood (ages 5, 10)–Adulthood (ages 20, 30, 40, 50, 55, 60, 65) | 9 | 16 years |
| Straughen, 2018 29 | GMM |
|
Linear | R—lcmm | 4 |
|
Yes | Self‐reported BMI (percentiles) | Young adulthood–adulthood (from 18 to 45 years) | 3 | 27 years |
| Tu, 2015 22 | GBTM |
|
Quadratic, cubic | Stata program developed by jones and nagin | 4 |
|
No | Self‐reported BMI | Childhood–adolescent (1–20 years) | 8 | 16 years (19–35) |
| VanWagner, 2018 40 | Latent mixture modeling |
|
N/A | SAS—proc traj | 4 |
|
No | Percentage change in measured BMI relative to baseline | Young adulthood–adulthood (18–60) | 8 | ∼19 years |
| Viner, 2019 44 | LGMM |
|
N/A | Mplus—mixture command | 3 |
|
No | Measured BMI at 10 and 16, self‐reported at other ages | Childhood (10, 16) –adulthood (26, 30, 34, 42) | 6 | 32 years |
| Vistisen, 2014 54 | Latent class trajectory analysis | BIC | Cubic | R—lcmm, hlme function | 3 |
|
No | Measured BMI | Adulthood (35–55 years of age) | 4 | Mean 14.1 years (Interquartile range (IQR) 8.7–16.2 years) |
| Votruba, 2014 37 | LCGM |
|
Linear and quadratic | SAS—proc traj | 8 |
|
No | Body weight (kg) | Young adulthood–adulthood (baseline at 18‐24, measured until 45) | At least 4 (range 4–14) | Median 16 years (IQR 11–25 years) |
| Wang, 2015 67 | LCGM |
|
Quadratic, cubic | SAS—proc traj | 4 |
|
No | Self‐reported BMI | Young adulthood (20 years) –Midadulthood (55 years) | Up to 9 | 36 years |
| Wang, 2016 55 | LCGM |
|
Quadratic, linear | SAS | 4 |
|
No | Self‐reported BMI | Adulthood–older adulthood (40–70 years) |
|
|
| Wang, 2017 62 | LCGM |
|
Quadratic | SAS | 4 |
|
No | Self‐reported BMI | Older adulthood (65–94 years) | 8 | 14 years |
| Wijnstok, 2013 36 | LCGA | BIC | Linear | Mplus |
|
|
No | Measured BMI, S4SFs, SFR | Childhood (13 years)–adulthood (42 years) | 9 | 55 years (5–60 years) |
| Williams, 2017 45 | GBTM | BIC | Quantic and quartic | SAS—proc traj | 4 |
|
No | Measured BMI | Childhood (3, 5, 7, 9, 11, 13, 15, 18 years)–Adulthood (21, 26, 32, 38 years) | 9 | 60 years |
| Xian, 2017 24 | LCGM) analysis | LMR likelihood ratio test | Linear and quadratic | Mplus | 3 |
|
No | Measured BMI at baseline, 56, and 62; self‐reported BMI at 40 | Young adulthood (20)–adulthood (62) | 4 | 42 years |
| Yang, 2017 65 | LCGBTM | BIC | Cubic | SAS—proc traj | 5 |
|
No | Self‐reported BMI | Young adulthood (18)–adulthood (35, 50–71) | 4 | 32–53 years |
| Zajacova, 2014 61 | Joint GMM‐DTSA |
|
Linear | Mplus | 3 |
|
Yes (trajectory 3) | Self‐reported BMI | Older adulthood (61–87 years) | 8 | 31 years |
| Zheng, 2013 56 | Semiparametric group‐based trajectory model | BIC | N/A | SAS—proc traj | 6 |
|
Yes (trajectory 6) | Self‐reported BMI | Adulthood–older adulthood (51–77) | 9 | 30 years |
| Zheng, 2018 68 | Group‐based trajectory modeling (GBTM) |
|
Quadratic | SAS—proc traj | 5 |
|
No | Measured BMI | Young adulthood–older adulthood (17–94) | 5 | Mean 3.84 SD 0.97 years |
Abbreviations: AIC, Akaike's Information Criteria; BIC, Bayesian Information Criteria; BMI, body mass index; CI: Confidence intervals; FIML, full information maximum likelihood; GBTM, group‐based trajectory modeling; GGMM, general growth mixture modeling; GMM, general mixture modeling; GMM‐DTSA, growth mixture‐discrete‐time survival analysis model; LCGA, latent class growth analysis; LCGBTM, latent class group‐based trajectory models; LCGM, latent class growth model; LCGMM, latent class growth mixture modeling; LRT, Likelihood‐ratio test; LMR, Lo‐Mendell‐Rubin; OCC, odds of correct classification; S4SF, sum of four skinfolds; SFR, skinfold thickness ratio; SPMM, semiparametric mixture models.
The number of growth measures used to estimate trajectories ranged from 3 to 16, with a mean of 6.2 (SD = 2.7). The mean trajectory duration (time between first and last anthropometric measurement) was 29.2 years (SD = 17.1). 22 studies that began growth assessment in childhood 5 , 14 , 18 , 20 , 22 , 30 , 31 , 32 , 36 , 38 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 and extended into adulthood. Of these 22 studies with growth trajectories beginning in childhood, five studies 20 , 22 , 38 , 41 , 51 had measures until young adulthood (19–23 years old), 12 studies 16 , 30 , 31 , 32 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 had measures until midadulthood (38–50 years old), and five studies 5 , 14 , 17 , 18 , 46 had measures until older adulthood (60–80 years old). The remaining studies (n = 37) 15 , 19 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 33 , 34 , 35 , 39 , 40 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 did not include any childhood measures, and only included measures >18 years of age. Of these 37 studies that only reported growth measures in adulthood, six studies 26 , 61 , 62 , 63 , 64 , 70 only included measures during the older adulthood period of life (≥60 years of age).
3.3. Statistical approach
As described in Table 3, most studies (n = 33) used the statistical software SAS with the procedure PROC TRAJ 73 to estimate trajectories. Mplus was used by 11 studies and three of these stated full information maximum likelihood (FIML) was used, two stated general mixture modeling was used, and the others did not specify the specific procedure in Mplus. Only four studies used the statistical software R 74 to estimate trajectories, and all fit latent class mixed models using the extended mixed models using latent classes and latent processes (lcmm) package. 75 The final software that was used to estimate trajectories was STATA, TRAJ procedure 76 (n = 11).
3.4. Model fit criteria
The studies used various model fit criteria to determine the number of trajectories that optimally fit the data. The most commonly method was the Bayesian Information Criteria, which was used by almost all studies (n = 54). Studies also used a combination of the Akaike's Information Criteria, Lo‐Mendell‐Rubin likelihood ratio test, odds of correct classification, posterior probability, significance of polynomial terms, and a priori knowledge to inform the creation of trajectories. Only nine studies included entropy as a criterion for model fit, with the most commonly reported cutoff of >1%. The most common polynomial terms that were found to be significant were quadratic and cubic polynomial terms (Table 3).
3.5. Number and naming of identified trajectories
The number of trajectories that studies identified ranged from 2 to 9. Most studies (56%) found the optimal number of trajectories was 4. Fifteen studies identified five trajectories, and 11 studies identified three trajectories to best fit the data. A sample plot illustrating a 5‐trajectory model from an included study 35 can be found in Figure 2. The names that were given to the trajectories varied greatly across all studies; however, names were commonly generated based on visual assessments. Most studies used terms such as “normal,” “normative,” “low,” or “stable” to describe the trajectory defined by the lowest weight/BMI throughout the life course. Other common terms used to name trajectories include, “increasing,” “decreasing,” “overweight,” “obese,” and “persistent”. Five studies did not name their identified trajectories, and only referred to the trajectories by group or class number. A detailed description of the various names used to describe the trajectories in each study can be found in Table 3.
FIGURE 2.

5‐trajectory plot from included study
The prevalence of the identified trajectories varied, for example the “normal” or “lean stable” trajectory ranged from 14% to 91% of the study populations. Whereas the trajectory with the lowest prevalence was most often the highest growth trajectory, often defined as “persistent obesity” and ranged from 0.8% to 10.5%. 26 studies identified a trajectory defined by a sharp increase in weight throughout the life course and the prevalence of this trajectory varied greatly, ranging from 3% to 29.2%. Only 10 studies identified a trajectory which had a resolving pattern, meaning it began with a higher BMI or body size in earlier life and decreased over the life course and the prevalence ranged from 1.6% to 16%. No studies identified a trajectory characterized by a persistent underweight status.
3.6. Sex differences
Of the 59 included studies, 19 studies stratified trajectories by sex and 13 studies only included sex‐specific populations (i.e., males only or females only). Two studies 41 , 66 reported they stratified trajectories by sex, however results were not reported since the results were similar to crude analyses. For most studies, the names and number of trajectories were consistent in both men and women, however visual inspection showed slight differences. When comparing trajectories characterized by persistent obesity, the prevalence for males ranged from 0.8% to 16.2%, compared to the prevalence in females, 2.2% to 14%.
3.7. Outcome association
A description of the outcomes that were evaluated in relation to BMI/body size trajectories can be found in Table 4. Twenty‐two studies evaluated disease‐related outcomes including cancer, cardiovascular disease, or diabetes. About 15% of studies (n = 9) evaluated characteristics associated with trajectories or the association between trajectories and weight later in life. Two studies evaluated maternal trajectories and the association with outcomes in offspring. The remaining trajectories evaluated associations with various outcomes. Although it is difficult to draw conclusions regarding the association between BMI/body size trajectories and disease‐related outcomes due to the heterogeneity of trajectory methodology and outcomes assessed, it appears that trajectories with persistent obesity or trajectories defined by the highest weight throughout the life course typically had the greatest risk of disease related outcomes.
TABLE 4.
Details of outcomes evaluated in relation to BMI/body size trajectories (n = 51) a
| Outcome evaluated | Number of studies | References |
|---|---|---|
| Characteristics BMI trajectories/weight gain | 9 | 19, 20, 22, 37, 52, 53, 63, 64, 67 |
| Cancer | 8 | 5, 25, 27, 30, 31, 35, 59, 65 |
| Cardiovascular disease | 8 | 24, 36, 43, 45, 46, 49, 51, 66 |
| Diabetes | 6 | 32, 33, 54, 68, 72 |
| Mortality | 4 | 16, 56, 61, 62 |
| Overall health outcomes | 3 | 21, 55, 69 |
| Insomnia/sleepiness | 2 | 47, 48 |
| Childhood outcomes | 2 | 28, 29 |
| Genetics and biomarkers | 2 | 14, 18 |
| Other | 7 | 34, 40, 42, 50, 60, 70, 71 |
Abbreviation: BMI, body mass index.
Eight studies were excluded since they modeled BMI/body size trajectories as the outcome.
4. DISCUSSION
The results from this scoping review suggest that four distinct trajectories of body size across the life course, including adulthood, are commonly identified. This review is the first to evaluate growth trajectories across the entire life course using different anthropometric measures. The findings from this review are consistent with a previous systematic review 41 , 66 of trajectories ranging from birth to age 18 only, which found three or four distinct BMI trajectories were most often identified. The average number of growth measures used to identify trajectories was 6.2, with on average 29 years between the first and last anthropometric measures. Most studies did not include a growth assessment during childhood, including only growth measures ≥18 years of age. The methodologies used to identify and estimate trajectories varied across studies in terms of model building approaches, statistical software used, and characteristics of trajectories. Future studies may consider clearly reporting the methodologies used to identify and estimate the trajectories, to allow for transparent reporting.
Due to the heterogeneity of outcomes that were evaluated in relation to the identified trajectories, it was not possible to conduct a meta‐analysis. Although findings varied across studies, it was evident that trajectories defined by the highest body weight or BMI at all ages were most often associated with the greatest risk of disease‐related outcomes. Many studies identified a persistent overweight trajectory and it was generally associated with increased risk, but not always as strongly as the trajectory characterized by persistent obesity. Furthermore, some studies identified a progressive obesity trajectory with lower body size or BMI in childhood or younger adulthood that increased to overweight and obesity later in life, and this trajectory was generally associated with an elevated risk. Only one study identified a trajectory that had high body weight but decreased in later years and no studies identified an underweight trajectory; therefore, making it difficult to comment on the impact of obesity or overweight in childhood or young adulthood as a sensitive period. Future studies that evaluate growth across the life course and disease related outcomes can continue to accumulate evidence identifying sensitive or critical periods of development throughout the life course. 77 Typically, in epidemiologic research, an exposure is assessed immediately preceding the development of disease. The use of longitudinal data can explain variation in development throughout the life course, and how that may in turn impact the development of an outcome.
Most studies used the statistical approach PROC TRAJ in SAS, with only four studies using lcmm in R. The low number of studies that utilized the R package may have been because of the recent development of this statistical package. 75 It is the newest program, which may explain why the least amount of studies used this software. Although the statistical approaches and software are identifying group‐based trajectories, there is limited literature directly comparing each approach. Each program must be downloaded as an additional package or plugin as they are not found in the base program, except the FIML procedure in Mplus. All programs use some form of maximum likelihood estimation, which is a general approach for estimating parameters of a probability density function. TRAJ in STATA was adapted from PROC TRAJ in SAS, and therefore use similar methodologies. 76 PROC TRAJ in SAS uses covariance structure methods, whereas the lcmm package in R estimates models with a mixture of linear mixed effects models, allowing for latent classes and random effects to account for repeated measures on subjects. 75
Although the use of group‐based trajectory modeling is a novel approach, there are several inconsistencies in model building approaches throughout the literature. This limits the generalizability of findings and thus limiting the ability to compare findings across studies. A recent framework by Lennon et al., 78 outlines an 8‐step framework which can be used by researchers to ensure group‐based trajectory models are developed in a systematic way. Future studies may benefit from following this framework as it may provide guidance during identification of the most optimal trajectory model. In addition, Guidelines for Reporting on Latent Trajectory Studies (GRoLTS‐Checklist), 79 which is a 16‐item checklist designed to increase transparently and uniformity of presenting results in latent trajectory studies, was also recently developed. Given that these tools were only recently published, none of the identified studies reported using either the framework or checklist to guide their studies. A formal application of the GRoLTS‐Checklist was beyond the scope of the current project and therefore was not applied. Generally, items addressing the software used, shape and functional forms, metric of time used, and the characteristics of the final class solution were addressed or reported by the studies. Whereas, items surrounding reporting of missing data, information on the distribution of the observed variables and the entropy were not frequently reported. The gaps in reporting following the GRoLTS‐Checklist can inform where future studies When comparing the studies that used the same study populations, it was evident that differences did exist. However, this may be related to differences in the objectives of the studies leading to slightly different participants in the study. For instance, the NLSY was used by five studies. Three of these studies 20 , 21 , 22 reported four trajectories, whereas the remaining two studies reported three 20 , 21 , 22 and five 20 , 21 , 22 trajectories. When the use of the GRoLTS‐Checklist, it would be immediately apparent as to why the different number of trajectories were identified among the same sample and would allow for an easy comparison to be made.
Strengths of this study included the large number of studies that were identified using a systematic search to identify eligible studies. The search strategy was developed, and health research librarians reviewed it to ensure all relevant and necessary search terms were included, and all potentially eligible studies were identified. The broad inclusion of any measure of growth, in terms of BMI and body size, did not limit the identification of any studies that used group‐based approaches to measure growth across the life course. Most studies relied on self‐reported BMI (44%) as the anthropometric measure of growth, which is common in epidemiologic research when resources are limited, and it is not possible to use objective measurements to assess body weight. It has been noted that the use of self‐report of BMI 81 , 82 or self‐reported recall of BMI 83 is a valid measure of true BMI. When evaluating the average number of identified trajectories among studies that used self‐reported BMI and measured BMI separately, the average number of trajectories remains 4 for both methods.
Using life course trajectories provides a much more comprehensive understanding of the impact of differential growth patterns. Group‐based trajectory modeling is a novel approach to identify various patterns of growth throughout the life course. The findings from this review may inform future epidemiologic research on the commonly used methodologies and approaches used to generate group‐based trajectories of growth across the life course. In addition, the use of growth trajectories can be used to inform future public health interventions or prevention strategies targeting subgroups that are at a high‐risk of negative health‐related outcomes.
CONFLICT OF INTEREST
All authors declare no conflict of interest.
Supporting information
Supporting Information 1
ACKNOWLEDGMENT
This work was supported by the Canadian Institutes of Health Research.
References
REFERENCES
- 1. World Health Organization . Obesity and overweight. 2020. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
- 2. Centers for Disease Control and Prevention . Prevalence of childhood obesity in the United States. 2020. https://www.cdc.gov/obesity/data/childhood.html.
- 3. Nader PR, O'Brien M, Houts R, et al. Identifying risk for obesity in early childhood. Pediatrics. 2006;118(3):e594‐e601. 10.1542/peds.2005-2801. [DOI] [PubMed] [Google Scholar]
- 4. Ventura AK, Loken E, Birch LL. Developmental trajectories of girls' BMI across childhood and adolescence. Obesity (Silver Spring). 2009;17(11):2067‐2074. 10.1038/oby.2009.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Song M, Willett WC, Hu FB, et al. Trajectory of body shape across the lifespan and cancer risk. Int J Canc. 2016;138(10):2383‐2395. 10.1002/ijc.29981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatr Psychol. 2014;39(2):188‐203. 10.1093/jpepsy/jst085. [DOI] [PubMed] [Google Scholar]
- 7. Regnault N, Gillman MW. Importance of characterizing growth trajectories. Ann Nutr Metab. 2014;65(2‐3):110‐113. 10.1159/000365893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Cole VT, Bauer DJ. A note on the use of mixture models for individual prediction. Struct Equ Model. 2016;23(4):615‐631. 10.1080/10705511.2016.1168266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. von Kries R, Beyerlein A, Müller MJ, et al. Different age‐specific incidence and remission rates in pre‐school and primary school suggest need for targeted obesity prevention in childhood. Int J Obes (Lond). 2012;36(4):505‐510. 10.1038/ijo.2011.251. [DOI] [PubMed] [Google Scholar]
- 10. Mattsson M, Maher G, Fiona B, Fitxgerald A, Murray DM, Biesma R. Group‐based trajectory modelling for BMI trajectories in childhood: a systematic review. Obes Rev. 2019:1‐19. [DOI] [PubMed] [Google Scholar]
- 11. U.S. National Library of Medicine . Growth MeSH descriptor data. 2020. https://meshb.nlm.nih.gov/record/ui?ui=D006128.
- 12. World Health Organization . WHO child growth standards: Methods and development. 2020. https://www.who.int/childgrowth/standards/technical_report/en/.
- 13. Covidence systematic review software, Veritas Health Innovation , Melbourne, Australia. 2020. Available at https://www.covidence.org.
- 14. Hang D, Nan H, Kværner AS, et al. Longitudinal associations of lifetime adiposity with leukocyte telomere length and mitochondrial DNA copy number. Eur J Epidemiol. 2018;33(5):485‐495. 10.1007/s10654-018-0382-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Jun HJ, Corliss HL, Nichols LP, et al. Adult body mass index trajectories and sexual orientation: the Nurses' Health Study II. Am J Prev Med. 2012;42(4):348‐354. 10.1016/j.amepre.2011.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Song M, Hu FB, Wu K, et al. Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies. BMJ. 2016;353:i2195. 10.1136/bmj.i2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Song M, Zheng Y, Qi L, Hu FB, Chan AT, Giovannucci EL. Associations between genetic variants associated with body mass index and trajectories of body fatness across the life course: a longitudinal analysis. Int J Epidemiol. 2018;47(2):506‐515. 10.1093/ije/dyx255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Kvoerner A, Hang D, Giovannucci E, Willett W, Chan AT, Song M. Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin‐insulin‐like growth factor system. Am J Clin Nutr. 2018;108:388‐397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Malhotra R, Ostbye T, Riley CM, Finkelstein EA. Young adult weight trajectories through midlife by body mass category. Obesity (Silver Spring). 2013;21(9):1923‐1934. 10.1002/oby.20318. [DOI] [PubMed] [Google Scholar]
- 20. Nonnemaker JM, Morgan‐Lopez AA, Pais JM, Finkelstein EA. Youth BMI trajectories: evidence from the NLSY97. Obesity (Silver Spring). 2009;17(6):1274‐1280. 10.1038/oby.2009.5. [DOI] [PubMed] [Google Scholar]
- 21. Ostbye T, Malhotra R, Landerman LR. Body mass trajectories through adulthood: results from the National Longitudinal Survey of Youth 1979 Cohort (1981‐2006). Int J Epidemiol. 2011;40(1):240‐250. 10.1093/ije/dyq142. [DOI] [PubMed] [Google Scholar]
- 22. Tu AW, Mâsse LC, Lear SA, Gotay CC, Richardson CG. Body mass index trajectories from ages 1 to 20: results from two nationally representative canadian longitudinal cohorts. Obesity (Silver Spring). 2015;23(8):1703‐1711. 10.1002/oby.21158. [DOI] [PubMed] [Google Scholar]
- 23. Huang DY, Lanza HI, Anglin MD. Association between adolescent substance use and obesity in young adulthood: a group‐based dual trajectory analysis. Addict Behav. 2013;38(11):2653‐2660. 10.1016/j.addbeh.2013.06.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Xian H, Vasilopoulos T, Liu W, et al. Steeper change in body mass across four decades predicts poorer cardiometabolic outcomes at midlife. Obesity (Silver Spring). 2017;25(4):773‐780. 10.1002/oby.21791 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Kelly SP, Graubard BI, Andreotti G, Younes N, Cleary SD, Cook MB. Prediagnostic body mass index trajectories in relation to prostate cancer incidence and mortality in the PLCO cancer screening trial. J Natl Cancer Inst. 2017;109(3). 10.1093/jnci/djw225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Laddu DR, Cawthon PM, Parimi N, et al. Trajectories of the relationships of physical activity with body composition changes in older men: the MrOS study. BMC Geriatr. 2017;17:119. 10.1186/s12877-017-0506-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Lavalette C, Cordina Duverger E, Artaud F, et al. Body mass index trajectories and prostate cancer risk: results from the EPICAP study. Cancer Med. 2020;9:6421–6429. 10.1002/cam4.3241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Adane AA, Mishra GD, Tooth LR. Maternal preconception weight trajectories, pregnancy complications and offspring's childhood physical and cognitive development. J Dev Orig Health Dis. 2018;9(6):653‐660. 10.1017/S2040174418000570. [DOI] [PubMed] [Google Scholar]
- 29. Straughen JK, Bazydlo M, Havstad S, Shafie‐Khorassani F, Misra DP. Maternal body weight trajectories across the life course and risk of preterm delivery. J Dev Orig Health Dis. 2018;9(2):143‐150. 10.1017/S2040174417000708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Amadou A, Torres Mejia G, Fagherazzi G, et al. Anthropometry, silhouette trajectory, and risk of breast cancer in Mexican women. Am J Prev Med. 2014;46(3 suppl 1):S52‐S64. 10.1016/j.amepre.2013.10.024. [DOI] [PubMed] [Google Scholar]
- 31. Fagherazzi G, Guillas G, Boutron‐Ruault MC, Clavel‐Chapelon F, Mesrine S. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort. Eur J Cancer Prev. 2013;22(1):29‐37. 10.1097/CEJ.0b013e328355ec04. [DOI] [PubMed] [Google Scholar]
- 32. Fagherazzi G, Vilier A, Affret A, Balkau B, Bonnet F, Clavel‐Chapelon F. The association of body shape trajectories over the life course with type 2 diabetes risk in adulthood: a group‐based modeling approach. Ann Epidemiol. 2015;25(10):785‐787. 10.1016/j.annepidem.2015.06.002. [DOI] [PubMed] [Google Scholar]
- 33. Kakoly NS, Earnest A, Moran LJ, Teede HJ, Joham AE. Group‐based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community‐based longitudinal study. BMC Med. 2017;15(1):195. 10.1186/s12916-017-0957-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Ito A, Hayashi K, Suzuki S, et al. Association of trajectory of body mass index with knee pain risk in Japanese middle‐aged women in a prospective cohort study: the Japan Nurses' Health Study. BMJ Open. 2020;10(2):e033853. 10.1136/bmjopen-2019-033853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. De Rubeis V, Cotterchio M, Smith BT, et al. Trajectories of body mass index, from adolescence to older adulthood, and pancreatic cancer risk; a population‐based case‐control study in Ontario, Canada. Cancer Causes Control. 2019;30:955–966. 10.1007/s10552-019-01197-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Wijnstok NJ, Serné EH, Hoekstra T, Schouten F, Smulders YM, Twisk JW. The relationship between 30‐year developmental patterns of body fat and body fat distribution and its vascular properties: the Amsterdam Growth and Health Longitudinal Study. Nutr Diabetes. 2013;3:e90. 10.1038/nutd.2013.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Votruba SB, Thearle MS, Piaggi P, Knowler WC, Hanson RL, Krakoff J. Weight maintenance from young adult weight predicts better health outcomes. Obesity (Silver Spring). 2014;22(11):2361‐2369. 10.1002/oby.20854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Kwon S, Janz KF, Letuchy EM, Burns TL, Levy SM. Active lifestyle in childhood and adolescence prevents obesity development in young adulthood. Obesity (Silver Spring). 2015;23(12):2462‐2469. 10.1002/oby.21262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Jeon J, Jung KJ, Jee SH. Waist circumference trajectories and risk of type 2 diabetes mellitus in Korean population: the Korean genome and epidemiology study (KoGES). BMC Publ Health. 2019;19(1):741. 10.1186/s12889-019-7077-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. VanWagner LB, Khan SS, Ning H, et al. Body mass index trajectories in young adulthood predict non‐alcoholic fatty liver disease in middle age: the CARDIA cohort study. Liver Int. 2018;38(4):706‐714. 10.1111/liv.13603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Elsenburg LK, Smidt N, Hoek HW, Liefbroer AC. Body mass index trajectories from adolescence to early young adulthood: do adverse life events play a role? Obesity (Silver Spring). 2017;25(12):2142‐2148. 10.1002/oby.22022. [DOI] [PubMed] [Google Scholar]
- 42. Sayon‐Orea C, Bes‐Rastrollo M, Song M, et al. Body shape trajectories and incidence of depression in the "Seguimiento Universidad de Navarra" (SUN) prospective cohort. J Affect Disord. 2019;251:170‐179. 10.1016/j.jad.2019.01.055. [DOI] [PubMed] [Google Scholar]
- 43. Sayon‐Orea C, Bes‐Rastrollo M, Song M, et al. Body shape trajectories and the incidence of hypertension in a Mediterranean cohort: the sun study. Nutr Metab Cardiovasc Dis. 2019;29(3):244‐253. 10.1016/j.numecd.2018.12.004. [DOI] [PubMed] [Google Scholar]
- 44. Viner RM, Costa S, Johnson W. Patterns of BMI development between 10 and 42 years of age and their determinants in the 1970 British Cohort Study. J Epidemiol Community Health. 2019;73(1):79‐85. 10.1136/jech-2018-211051. [DOI] [PubMed] [Google Scholar]
- 45. Williams MJA, Milne BJ, Ambler A, et al. Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlife. Int J Obes (Lond). 2017;41(9):1355‐1360. 10.1038/ijo.2017.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Islam MT, Möller J, Zhou X, Liang Y. Life‐course trajectories of body mass index and subsequent cardiovascular risk among Chinese population. PLoS One. 2019;14(10):e0223778. 10.1371/journal.pone.0223778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Lisan Q, Tafflet M, Charles MA, et al. Self‐reported body silhouette trajectories across the lifespan and excessive daytime sleepiness in adulthood: a retrospective analysis. The Paris Prospective Study III. BMJ Open. 2018;8(3):e020851. 10.1136/bmjopen-2017-020851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Lisan Q, Tafflet M, Thomas F, et al. Body silhouette trajectories over the lifespan and insomnia symptoms: the Paris prospective study 3. Sci Rep. 2019;9(1):1581. 10.1038/s41598-018-38145-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Buscot MJ, Thomson RJ, Juonala M, et al. Distinct child‐to‐adult body mass index trajectories are associated with different levels of adult cardiometabolic risk. Eur Heart J. 2018;39(24):2263‐2270. 10.1093/eurheartj/ehy161. [DOI] [PubMed] [Google Scholar]
- 50. Oura P, Junno JA, Auvinen J, et al. Body mass index trajectories from birth to midlife and vertebral dimensions in midlife: the northern Finland birth cohort 1966 study. JBMR Plus. 2019;3(1):37‐44. 10.1002/jbm4.10065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Ahanchi NS, Ramezankhani A, Munthali RJ, Asgari S, Azizi F, Hadaegh F. Body mass index trajectories from adolescent to young adult for incident high blood pressure and high plasma glucose. PLoS One. 2019;14(5):e0213828. 10.1371/journal.pone.0213828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Botoseneanu A, Liang J. Latent heterogeneity in long‐term trajectories of body mass index in older adults. J Aging Health. 2013;25(2):342‐363. 10.1177/0898264312468593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Jayne JM, Blake CE, Frongillo EA, et al. Trajectories of body mass index among active‐duty U.S. Army soldiers, 2011‐2014. Prev Med Rep. 2019;14:100818. 10.1016/j.pmedr.2019.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Vistisen D, Witte DR, Tabák AG, et al. Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med. 2014;11(2):e1001602. 10.1371/journal.pmed.1001602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Wang M, Yi Y, Roebothan B, et al. Body mass index trajectories among middle‐aged and elderly Canadians and associated health outcomes. J Environ Public Health. 2016;2016:7014857. 10.1155/2016/7014857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Zheng H, Tumin D, Qian Z. Obesity and mortality risk: new findings from body mass index trajectories. Am J Epidemiol. 2013;178(11):1591‐1599. 10.1093/aje/kwt179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic‐review protocols. Lancet. 2011;377(9760):108‐109. 10.1016/S0140-6736(10)60903-8. [DOI] [PubMed] [Google Scholar]
- 58. Clarke PJ, O'Malley PM, Schulenberg JE, Lee H, Colabianchi N, Johnston LD. College expectations in high school mitigate weight gain over early adulthood: findings from a national study of American youth. Obesity (Silver Spring). 2013;21(7):1321‐1327. 10.1002/oby.20176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Petrick JL, Kelly SP, Liao LM, Freedman ND, Graubard BI, Cook MB. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH‐AARP and PLCO Studies. Br J Canc. 2017;116(7):951‐959. 10.1038/bjc.2017.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Elrashidi MY, Jacobson DJ, St Sauver J, et al. Body mass index trajectories and healthcare utilization in young and middle‐aged adults. Medicine (Baltimore). 2016;95(2):e2467. 10.1097/MD.0000000000002467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Zajacova A, Ailshire J. Body mass trajectories and mortality among older adults: a joint growth mixture‐discrete‐time survival analysis. Gerontol. 2014;54(2):221‐231. 10.1093/geront/gns164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Wang M, Yi Y, Roebothan B, et al. Trajectories of body mass index among Canadian seniors and associated mortality risk. BMC Publ Health. 2017;17(1):929. 10.1186/s12889-017-4917-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Reinders I, Murphy RA, Martin KR, et al. Body mass index trajectories in relation to change in lean mass and physical function: the health, aging and body composition study. J Am Geriatrics Soc. 2015;63(8):1615‐1621. 10.1111/jgs.13524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Kuchibhatla MN, Fillenbaum GG, Kraus WE, Cohen HJ, Blazer DG. Trajectory classes of body mass index in a representative elderly community sample. J Gerontol A Biol Sci Med Sci. 2013;68(6):699‐704. 10.1093/gerona/gls215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Yang B, Petrick JL, Kelly SP, Graubard BI, Freedman ND, McGlynn KA. Adiposity across the adult life course and incidence of primary liver cancer: the NIH‐AARP cohort. Int J Canc. 2017;141(2):271‐278. 10.1002/ijc.30737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Fan B, Yang Y, Dayimu A, et al. Body mass index trajectories during young adulthood and incident hypertension: a longitudinal cohort in Chinese population. J Am Heart Assoc. 2019;8(8):e011937. 10.1161/JAHA.119.011937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Wang M, Yi Y, Roebothan B, et al. Trajectories of body mass index from young adulthood to middle age among Canadian men and women. Adv Epidemiol. 2015;1–11. 10.1155/2015/121806. [DOI] [Google Scholar]
- 68. Zheng Q, Jiang S, Zhang R, et al. Association between BMI trajectory and the risk of diabetes mellitus: a prospective cohort study. Int J Clin Exp Med. 2018;11:2406‐2413. [Google Scholar]
- 69. Clarke PJ, O'Malley PM, Schulenberg JE, Johnston LD. Midlife health and socioeconomic consequences of persistent overweight across early adulthood: findings from a national survey of American adults (1986‐2008). Am J Epidemiol. 2010;172(5):540‐548. 10.1093/aje/kwq156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Ho HE, Yeh CJ, Chu WM, Lee MC. Midlife body mass index trajectory and risk of frailty 8 Years later in Taiwan. J Nutr Health Aging. 2019;23(9):849‐855. 10.1007/s12603-019-1226-6. [DOI] [PubMed] [Google Scholar]
- 71. Salmela J, Lallukka T, Mauramo E, Rahkonen O, Kanerva N. Body mass index trajectory‐specific changes in economic circumstances: a person‐oriented approach among midlife and ageing Finns. Int J Environ Res Publ Health. 2020;17(10). 10.3390/ijerph17103668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Dai H, Li F, Bragazzi NL, et al. Distinct developmental trajectories of body mass index and diabetes risk: a 5‐year longitudinal study of Chinese adults. J Diabetes Investig. 2020;11(2):466‐474. 10.1111/jdi.13133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Jones A. Traj: Group‐Based Modeling of Longitudinal Data. Carneige Mellon University; 2018. https://www.andrew.cmu.edu/user/bjones/.
- 74. R Core Team. R . A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. https://www.R-project.org/.
- 75. Proust‐Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78(2):1–56. [Google Scholar]
- 76. Jones B, Nagin D. A stata plugin for estimating group‐based trajectory models. https://ssrc.indiana.edu/doc/wimdocs/2013-03-29_nagin_trajectory_stata-plugin-info.pdf. Accessed January 28, 2020.
- 77. World Health Organization . A life course approach to health. https://www.who.int/ageing/publications/lifecourse/alc_lifecourse_training_en.pdf.
- 78. Lennon H, Kelly S, Sperrin M, et al. Framework to construct and interpret latent class trajectory modelling. BMJ Open. 2018;8(7):e020683. 10.1136/bmjopen-2017-020683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. van de Schoot R, Sijbrandij M, Winter S, Depaoli S, Vermunt J. The GRoLTS‐Checklist: guidelines for reporting on latent trajectory studies. Struct Equ Modeling. 2017;24(3):451‐467. [Google Scholar]
- 80. Huang DY, Lanza HI, Wright‐Volel K, et al. Developmental trajectories of childhood obesity and risk behaviors in adolescence. J Adolesc. 2013;36(1):139‐148. 10.1016/j.adolescence.2012.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Kee CC, Lim KH, Sumarni MG, et al. Validity of self‐reported weight and height: a cross‐sectional study among Malaysian adolescents. BMC Med Res Methodol. 2017;17(1):85. 10.1186/s12874-017-0362-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Skeie G, Mode N, Henningsen M, Borch KB. Validity of self‐reported body mass index among middle‐aged participants in the Norwegian Women and Cancer study. Clin Epidemiol. 2015;7:313‐323. 10.2147/CLEP.S83839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. De Rubeis V, Bayat S, Griffith L, Smith B, Anderson L. Validity of self‐reported recall of early life adiposity: a systematic review and meta‐analysis. Obes Rev. 2018:1426–1440. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information 1
